Table 1.
Baseline patient and disease characteristics.
| Characteristic | GC80 (N = 456) | GC50 (N = 454) | GCb6 (N = 453) |
|---|---|---|---|
| Male | 286 (63%) | 291 (64%) | 268 (59%) |
| Female | 170 (37%) | 163 (36%) | 185 (41%) |
| Age | |||
| Median | 63 | 63 | 63 |
| IQ range | 57.5–68 | 57–69 | 57–68 |
| Range | 30–79 | 32–82 | 29–83 |
| Stagea | |||
| IIIB | 146 (32%) | 145 (32%) | 144 (32%) |
| IV | 310 (68%) | 309 (68%) | 309 (68%) |
| WHO PSa | |||
| 0 | 146 (32%) | 146 (32%) | 145 (32%) |
| 1 | 275 (60%) | 274 (60%) | 274 (60%) |
| 2 | 35 (8%) | 34 (8%) | 34 (8%) |
| Prior surgery | |||
| No | 427 (97%) | 416 (95%) | 412 (95%) |
| Yes | 15 (3%) | 20 (5%) | 23 (5%) |
| Not reported | 14 | 18 | 18 |
| Histology | |||
| Squamous | 149 (33%) | 152 (33%) | 156 (34%) |
| Adenocarcinoma | 169 (37%) | 156 (34%) | 182 (40%) |
| Large cell | 14 (3%) | 12 (3%) | 13 (3%) |
| Unspecified | 124 (27%) | 134 (30%) | 102 (23%) |
| BSA | |||
| N | 440 | 440 | 441 |
| Median | 1.82 | 1.84 | 1.82 |
| IQ range | 1.68–1.98 | 1.67–1.97 | 1.67–1.98 |
| Range | 1.35–2.26 | 1.26–2.45 | 1.28–2.49 |
| Target lesion size (mm) | |||
| N | 425 | 421 | 430 |
| Median | 82 | 82 | 83 |
| IQ range | 57–117 | 52–125 | 56–121 |
| Range | 4–553 | 5–389 | 10–420 |
WHO PS, World Health Organization performance status; IQ, interquartile; BSA, body surface area.
a
Indicates stratification factors.